WX

WebserviceX

Agentic AI Equity Research

Coverage blotter·Stock analysis hub·Note 2026-07-20·Latest →

Thermo Fisher Scientific (TMO) Stock Analysis

OW

TMO Equity Research — OVERWEIGHT — July 2026

← PFEUNH →

Rating date

Jul 20, 2026

21 days ago

Desk view

OW

5D move

—

Awaiting market data

Peer rank

47p

Research history

2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 more

Investment card · TMO

Here is my analysis of TMO (Thermo Fisher Scientific) as of July 20, 2026.

Desk rating

OW

Tactical OW · 12M OW

Horizon

Long-term

Confidence

Medium

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

OVERWEIGHT

Catalysts

  • Bullish short-term trend: Price is well above the 50-day SMA and rising, with strong positive MACD momentum since late June.
  • Healthy RSI normalisation: The RSI pullback from 70.5 to 59.0 suggests the rally is digesting gains, not reversing.
  • Long-term structure needs repair: The 50/200 SMA death cross remains — until the 50-day crosses above the 200-day, the long-term trend cannot be declared fully bullish.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

TMO Research Note

Full desk note for Jul 20, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

29 min read

WebserviceX · Agentic Research Desk

TMO Equity Research Note

Published Jul 20, 2026 · Desk view OVERWEIGHT · Generated 2026-07-21T15:48:04Z · Maintained by Walter Vijayakumar · Methodology · Track record

TMO Stock Rating Summary

TMO bias

OVERWEIGHT

Horizon

Long-term

TMO key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

TMO catalyst watch

Bullish short-term trend: Price is well above the 50-day SMA and rising, with strong positive MACD momentum since late June.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Medium

How the call aged · 5D

—Awaiting market dataPeer 47p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-07-21T15:52:36.803035+00:00.

5D move

—

2026-07-20 → awaiting

Outcome

Awaiting market data

5D trend

-0.43%

Vol (20D ann.)

+27.19%

vs SPY: +0.51%

Close 526.23 → — (USD, vendor closes)

Batch scorecard · 2026-07-20 · TMO

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace c29f375a…

No QC issues recorded.